A study to assess the safety, tolerability and pharmacokinetics of AZD4041 in Healthy Volunteers

Trial Identifier: D7460C00001
Sponsor: AstraZeneca
Collaborator:
National Institutes of Health (NIH)
Eolas Therapeutics INC.
NCTID:: NCT04076540
Start Date: October 2019
Primary Completion Date: January 2022
Study Completion Date: January 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations